文献速递消化系统肿瘤

miRNA-96-5p靶向FoxQ1抑制胃癌细胞增殖与迁移

[miRNA-96-5p inhibits the proliferation and migration of gastric cancer cells by targeting FoxQ1].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2019-01-01

该研究收集2015年6月至2017年1月手术切除的53例胃癌标本,检测miRNA-96-5p与FoxQ1表达并分析相关性。结果显示胃癌组织中miRNA-96-5p表达低于癌旁组织,FoxQ1阳性率高于癌旁组织,二者呈负相关;在BGC-823细胞中过表达miRNA-96-5p可抑制增殖与侵袭,并下调FoxQ1和Vimentin、上调E-cadherin。双荧光素酶实验证实FoxQ1为miRNA-96-5p靶基因。

要点

  • 胃癌组织中miRNA-96-5p中位表达为1.05,低于癌旁组织的3.23(P<0.05)。
  • 胃癌组织FoxQ1阳性率为71.7%,高于癌旁组织的28.3%(P<0.05)。
  • 过表达miRNA-96-5p可抑制BGC-823细胞增殖与侵袭(均P<0.05)。

核心结论

  • miRNA-96-5p在胃癌组织和细胞中表达下调,可能通过下调FoxQ1抑制胃癌细胞增殖、迁移和上皮间质转化。

研究设计与样本

  • 收集2015年6月至2017年1月手术切除的胃癌标本53例,采用实时荧光定量PCR检测miRNA-96-5p表达,免疫组化检测FoxQ1蛋白表达,并分析二者与临床病理特征的相关性。
  • 以miRNA-96-5p模拟物转染人胃癌BGC-823细胞,采用CCK-8法检测增殖、Transwell小室法检测侵袭、Western blot检测FoxQ1、E-cadherin和Vimentin蛋白表达,双荧光素酶活性实验验证靶向作用。

主要发现

  • 胃癌组织中miRNA-96-5p中位表达水平为1.05,低于癌旁组织的3.23(P<0.05)。
  • 胃癌组织中FoxQ1蛋白阳性表达率为71.7%,高于癌旁组织的28.3%(P<0.05)。
  • FoxQ1蛋白在胃癌组织中的表达与miRNA-96-5p表达呈负相关(r=-0.613,P=0.006)。
  • miRNA-96-5p在胃癌BGC-823细胞中的表达水平为0.96±0.08,低于正常胃黏膜上皮细胞GES-1的2.84±0.15(P<0.05)。
  • 与空白对照组和miRNA模拟物对照组BGC-823细胞比较,miRNA-96-5p模拟物组BGC-823细胞的增殖和侵袭能力均受到明显抑制(均P<0.05),且FoxQ1和Vimentin蛋白表达水平降低,E-cadherin蛋白表达水平增高;双荧光素酶报告基因检测显示FoxQ1是miRNA-96-5p的靶基因。

关键数值与推荐

  • 胃癌组织中miRNA-96-5p中位表达为1.05,癌旁组织为3.23,差异有统计学意义(P<0.05)。
  • 胃癌组织中FoxQ1蛋白阳性表达率为71.7%,癌旁组织为28.3%,差异有统计学意义(P<0.05)。
  • FoxQ1蛋白表达与miRNA-96-5p表达呈负相关(r=-0.613,P=0.006)。
  • 胃癌BGC-823细胞中miRNA-96-5p表达为0.96±0.08,正常胃黏膜上皮细胞GES-1为2.84±0.15,差异有统计学意义(P<0.05)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the role of microRNA-96-5p in the proliferation and invasion of gastric cancer cells and its molecular mechanism. Methods: From June 2015 to January 2017, 53 resected specimens were collected. The transcriptional levels of microRNA-96-5p and forkhead box Q1 (FoxQ1) in gastric cancer tissues and the matched para-cancerous tissues were quantified by quantitative real-time PCR (qRT-PCR). The expression of FoxQ1 protein was also detected by immunohistochemistry (IHC). The relationship between microRNA-96-5p expression and the clinicopathological features of gastric cancer and its correlation with FoxQ1 expression were analyzed. The expressions of miRNA-96-5p in gastric cancer tissue and adjacent normal tissue were detected by qRT-PCR. miRNA-96-5p mimics was transfected to BGC-823 gastric cancer cells. The effects of miRNA-96-5p on cell proliferation and invasion were detected by cell counting kit-8 (CCK-8) assay and Transwell assay, respectively. The protein expressions of FoxQ1, E-cadherin and vimentin were determined by western blot. The relationship between FoxQ1 and miRNA-96-5p expressed in BGC-823 cells was detected by dual-luciferase reporter assay. Results: The median expression of miRNA-96-5p in gastric cancer tissue was 1.05, significantly lower than 3.23 of para-cancerous tissues (P<0.05). The positive rate of FoxQ1 expression in gastric cancer tissue was 71.7%, significantly higher than 28.3% of para-cancerous tissues (P<0.05). The expression of FoxQ1 was negatively corelated with the level of miRNA-96-5p (r=-0.613, P=0.006). The expression of miRNA-96-5p in gastric cancer cell BGC-823 was significantly decreased compared with normal gastric epithelial cell (0.96±0.08 vs 2.84±0.15, P<0.05). The results of CCK-8 assay and Transwell assay showed that overexpression of miRNA-96-5p significantly reduced the proliferation and invasion abilities of gastric cancer cells (P<0.05). Overexpression of miRNA-96-5p decreased the protein level of FoxQ1. Moreover, it upregulated the expression of E-cadherin and downregulated the expression of vimentin. The result of dual-luciferase-3'-UTR reporter assay confirmed that miRNA-96-5p binds to the 3'UTR of FoxQ1. Conclusion: miRNA-96-5p may suppress the proliferation, migration and epithelial-mesenchymal transition (EMT) of gastric cancer cell by down-regulation of FoxQ1. 目的: 研究miRNA-96-5p在胃癌细胞和组织中的表达水平以及对胃癌细胞增殖、侵袭的影响和分子机制。 方法: 收集2015年6月至2017年1月手术切除的胃癌标本53例,采用实时荧光定量PCR法检测胃癌组织和癌旁组织中miRNA-96-5p的表达水平,采用免疫组化法检测叉头框蛋白Q1(FoxQ1)蛋白的表达,分析miRNA-96-5p的表达与胃癌患者临床病理特征和FoxQ1蛋白表达的相关性。采用实时荧光定量PCR法检测miRNA-96-5p在胃癌细胞和正常胃黏膜上皮细胞中的表达。以miRNA-96-5p模拟物转染人胃癌BGC-823细胞,采用细胞计数盒8(CCK-8)法检测BGC-823细胞的增殖,采用Transwell小室法检测BGC-823细胞的侵袭,采用Western blot法检测FoxQ1、E-cadherin和Vimentin蛋白的表达。采用双荧光素酶活性实验验证miRNA-96-5p对FoxQ1的靶向作用。 结果: 胃癌组织中miRNA-96-5p的中位表达水平为1.05,明显低于癌旁组织(3.23,P<0.05)。胃癌组织中FoxQ1蛋白的阳性表达率(71.7%)明显高于癌旁组织(28.3%,P<0.05)。相关性分析显示,FoxQ1蛋白在胃癌组织中的表达与miRNA-96-5p的表达呈负相关(r=-0.613,P=0.006)。miRNA-96-5p在胃癌BGC-823细胞中的表达水平为0.96±0.08,低于正常胃黏膜上皮细胞GES-1(2.84±0.15,P<0.05)。与空白对照组和miRNA模拟物对照组BGC-823细胞比较,miRNA-96-5p模拟物组BGC-823细胞的增殖和侵袭能力均受到明显抑制(均P<0.05),且miRNA-96-5p模拟物组BGC-823细胞中FoxQ1和Vimentin蛋白的表达水平降低,E-cadherin蛋白的表达水平增高。双荧光素酶报告基因检测结果显示,FoxQ1是miRNA-96-5p的靶基因。 结论: miRNA-96-5p在胃癌组织和细胞中表达下调,miRNA-96-5p通过调控FoxQ1基因的表达影响胃癌细胞的增殖、侵袭和上皮间质转化。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Yang XY, Li N, Deng WY, et al. [miRNA-96-5p inhibits the proliferation and migration of gastric cancer cells by targeting FoxQ1]. Zhonghua Zhong Liu Za Zhi. 2019. PMID: 30917455. doi:10.3760/cma.j.issn.0253-3766.2019.03.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。